Dr. Neel Kamal Gupta, MD

Dr. Gupta practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Gupta's NPI, 1144330416, was assigned on August 30, 2006. Dr. Gupta graduated from UC Davis School of Medicine in 2006. Dr. Gupta holds California license A111492.

Dr. Gupta's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Gupta's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Gupta is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Gupta to 2 more hospitals, each named with a free account. Dr. Gupta's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gupta practices, 4 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Gupta's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Gupta is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Gupta's licenses on file in 2 states: California and Washington.

Dmand AI lists anemia, breast cancer, chronic anemia, chronic leukemia, lymphoma and multiple myeloma among the conditions Dr. Gupta treats.

CMS data shows 1,086 Medicare services from Dr. Gupta across 7 procedure codes in 2024, for 257 Medicare patients. Medicare paid $120,046 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 257 Medicare patients who saw Dr. Gupta in 2024. The largest group is 75 to 84, with 108 patients. 70% of them have high blood pressure, and 70% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gupta's median patient age at 66, with 46% women.

In 2024, Dr. Gupta wrote 210 Medicare Part D claims for 30 patients. 72% of them were for generic drugs. CMS names the drug for 138 of them, across 6 drugs with 11 or more claims each, at $1,074,842 in total drug cost. In 2023, CMS named 66 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Gupta for performance year 2024, reported as part of a group. Dr. Gupta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gupta as offering telehealth.

Dmand AI links 21 papers to Dr. Gupta, published from 2013 to 2025. 2015 was the busiest year, with 2. The most frequent topics are Lymphoma, Large B-Cell, Diffuse, Antineoplastic Combined Chemotherapy Protocols and Antibodies, Monoclonal, Murine-Derived. Dr. Gupta has published most often in J Natl Compr Canc Netw. Dr. Gupta's most frequent co-authors are Gabriel Noah Mannis, MD, Ranjana Advani, MD and Richard Ambinder, MD.

Dmand AI links Dr. Gupta to 1 clinical trial. Conditions studied include Lymphoma, Large B-Cell, Diffuse and Lymphoma, B-Cell.

CMS Open Payments shows 20 general payments to Dr. Gupta from 11 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 63% of the total. Incyte Corporation paid the most, $4,698.

Dr. Gupta graduated from UC Davis School of Medicine in 2006.

Dr. Gupta is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.